MichaelPoraykoMDFAASLD

Gastroenterology • Brentwood, TN

Biliary Tract Disease, Hepatology & Liver Transplantation, Nutrition

Vanderbilt University Medical Center

Join to view full profile

Dr. Porayko is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Porayko's full profile

Already have an account?

Office
718 Sinclair Circle
Brentwood, TN 37027

Summary

I am board certified in Internal Medicine, Gastroenterology and Transplant Hepatology. Currently, I am a private Hepatology consultant.

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 1987 - 1988
Lahey ClinicFellowship, Gastroenterology, 1985 - 1987
Sparrow Hospital/Michigan State UniversityResidency, Internal Medicine, 1981 - 1985
University of Illinois College of MedicineClass of 1981

Certifications & Licensure

OR State Medical License 1989 - Present
TN State Medical License 2002 - 2025
AL State Medical License 2020 - 2020
MN State Medical License 1987 - 2002
PA State Medical License 1999 - 2002
MI State Medical License 1984 - 1988
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology
American Board of Internal Medicine Transplant Hepatology

Awards, Honors, & Recognition

Marquis Who's Who in the World Marquis Publications, 2019
America's Top Doctors Castle Connolly, 2010-2014
Nashville Lifestyles Magazine Castle Connolly, 2011, 2013-2014
America's Top Doctors for Cancer Castle Connolly, 2009-2013
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

Clinical Trials

Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients. Start of enrollment: 2013 Jun 01
Completed
Phase 3
Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy Start of enrollment: 2013 Apr 03
Terminated
Phase 4

Publications & Presentations

PubMed

9 citations
Differences in NAFLD/NASH Management by Provider Specialty: Opportunities for Optimizing Multidisciplinary Care.
Michael K Porayko, Amy Articolo, Wendy Cerenzia, Brandon Coleman, Daxa Patel
Journal of Multidisciplinary Healthcare. 2022-01-01
All tied up: not your typical distended abdomen.
Alexander P. Mamunes, Michael K. Porayko, Keith L. Obstein
Gastroenterology. 2021-08-28
35 citations
COMPASS: A Pilot Trial of an Early Palliative Care Intervention for Patients With End-Stage Liver Disease
Myrick C. Shinall, Mohana Karlekar, Sara F. Martin, Cheryl L Gatto, Sumi Misra
Journal of Pain and Symptom Management. 2019-10-01

Press Mentions

PharmaIN Unveils Interim Phase 1b Clinical Data on the Activity and Safety of PHIN-214 in Decompensated Liver Cirrhosis at AASLD - the Liver Meeting® 2024November 18th, 2024
PharmaIN to Present Promising Interim Data from Its Ongoing Phase 1 Trial of PHIN-214, an Optimized Vasopressor for Decompensated Cirrhosis, at the Liver Meeting® 2024October 16th, 2024

Grant Support

Effect Of Nutrition And Liver Transplantation On Protein MetabolismNational Center For Research Resources1996–1999
Pneumatic Trousers On Renal Hemodynamics/Function In CirrhosisNational Center For Research Resources1996

Professional Memberships

American College of Physicians - ACP
Member
American Gastroenterological Association - AGA
Member
American Association for the Study of Liver Diseases
Fellow
European Association for the Study of the Liver
Member